American Association for the Advancement of Science, Science Translational Medicine, 521(11), 2019
DOI: 10.1126/scitranslmed.aax0428
Full text: Unavailable
Cellular heterogeneity of PCa contributes to hormonal therapy failure, but CXCR2 on neuroendocrine cells is a potential therapeutic target.